https://www.selleckchem.com/
Given the importance of glycemic control for people with T2D, these results suggest that treatments which reduce rates of obesity may help to improve health outcomes. Diabetic gastroparesis may be associated with impaired nitric oxide metabolism and reduced tetrahydrobiopterin (BH ) synthesis. Oral treatment with CNSA-001 (sepiapterin, currently known as PTC923) increased BH levels in humans in a previous study. This Phase 2 study evaluated CNSA-001 in women with diabetic gastroparesis. Non-pregnant diabetic women with moderate/severe symptomatic gastropare
Kao
Komentar
Udio
